Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: A case report and literature review

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 76, Issue 2, 1998, Pages 237-240

  Milman, D ^a   Zalel, Y ^a   Biran, H ^a   Open, M ^a   Caspi, B ^a   Hagay, Z ^a   Dgani, R ^a  

^a KAPLAN HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; TRIPTORELIN;

ABDOMINAL HYSTERECTOMY; ABDOMINAL PAIN; ADULT; ARTICLE; CANCER DIAGNOSIS; EARLY DIAGNOSIS; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; LEIOMYOMA; LEIOMYOSARCOMA; PRIORITY JOURNAL; UTERUS BLEEDING;

EID: 0032007502     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(97)00211-X     Document Type: Article

References (21)

1. Friedman A.J., Harrison-Atlas D., Barbieri R.L., Benacerraf B., Gleason R., Schiff I. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata. Fertil Steril. 51:1989;251-256.
2. Stovall T.G. Gonadotropin-releasing hormone agonists: Utilization before hysterectomy. Clin Obstet Gynecol. 36:1993;652-659.
3. Schwartz L.B., Diamond M.P., Schwartz P.E. Leiomyosarcomas: Clinical presentation. Am J Obstet Gynecol. 168:1993;180-183.
4. Jones III HW, Wentz AC, Burnett LS. Novak's Textbook of Gynecology. 11th ed, Baltimore: Williams and Wilkins, 1988:761-72.
5. Leibsohn S., d'Ablaing G., Mishell D.R., Schlaerth J.B. Leiomyosarcoma in a series performed for presumed uterine leiomyomas. Am J Obstet Gynecol. 162:1990;968-976.
6. Parker W.H., Uao-Shi Fu., Berek J.S. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol. 83:1994;414-418.
7. Friedman A.J., Lobel S.M., Rein M.S., Barbieri R.L. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: The estrogen threshold hypothesis. Am J Obstet Gynecol. 163:1990;1114-1119.
8. Stovall T.G., Ling F.W., Henry L.C., Woodruff M.R. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas. Am J Obstet Gynecol. 164:1991;1420-1425.
9. Friedman A.J. Use of gonadotropin-releasing hormone agonists before myomectomy. Clin Obstet Gynecol. 36:1993;650-659.
10. Tamaya T., Fujimoto J., Okada H. Comparison of cellular levels of steroid receptors in uterine leiomyoma and myometrium. Acta Obstet Gynecol Scand. 64:1985;307-309.
11. Wiznitzer A., Marbach M., Hazum E., Insler V., Sharoni Y., Levy J. Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata. Biochem Biophys Res Commun. 152:1988;1326-1331.
12. Friedman A.J. Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment. Fertil Steril. 52:1989;152-154.
13. Meyer W.R., Mayer A.R., Diamond M.P., Carcangiu M.L., Schwartz P.E., DeCherney A.H. Unsuspected leiomyosarcoma: Treatment with a gonadotropin-releasing hormone analogue. Obstet Gynecol. 75:1990;529-531.
14. Loong E.P.L., Wong F.W.S. Uterine leiomyosarcoma diagnosed during treatment with agonist of luteinizing hormone-releasing hormone for presumed uterine fibroid. Fertil Steril. 54:1990;530-531.
15. Hitti I.F., Glasberg S.S., McKenzie C., Meltzer B.A. Uterine leiomyosarcoma with massive necrosis diagnosed during gonadotropin-releasing hormone analog therapy for presumed uterine fibroid. Fertil Steril. 56:1991;778-780.
16. Murphy N.J., Wallace D.L. Gonadotropin releasing hormone (GnRH) agonist therapy for reduction of leiomyoma volume. Gynecol Oncol. 49:1993;266-267.
17. Lee W.Y., Tzeng C.C., Chou C.Y. Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone-releasing hormone agonist. Gynecol Oncol. 52:1994;74-79.
18. Bell S.W., Kempson R.L., Hendrickson M.R. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 18:1994;535-558.
19. Kurjak A., Shalan S., Kupesic S., Predanic M., Zalud I., Breyer B., Jukic S. Transvaginal color Doppler sonography in the assessment of pelvic tumor vascularity. Ultrasound Obstet Gynecol. 3:1993;137-154.
20. Tepper R., Altaras M., Goldberger S., Zalel Y., Cordoba M., Beyth Y. Color Doppler ultrasonographic findings in low and high grade endometrial stromal sarcomas. JUM. 13:1994;817-819.
21. Andreyko J.L., Blumenfeld Z., Marshall L.A., Monroe S.E., Hricak H., Jaffe R.B. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: Assessment by magnetic resonance imaging. Am J Obstet Gynecol. 158:1988;903-910.